Optimal time of starting tocilizumab in acute phase of adult-onset Still ’s disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature

We examined the significance of TCZ in terms of therapeutic efficacy, reduction in glucocorticoid usage, and safety in patients with AOSD.•We compared the therapeutic efficacy of TCZ with that of MTX, which is often used to treat glucocorticoid-resistant AOSD.•TCZ is undoubtedly a valuable treatment option for AOSD, especially when administered at relapse, suggesting both high safety and good efficacy.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research